Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in Other Entecavir Trials

NCT01438424 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1053

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B Virus
HBV

Interventions

DRUG: Entecavir
DRUG: Lamivudine

Sponsor

Bristol-Myers Squibb